HUMAN HEALTH (01419) · Company profile · Eqvero

HUMAN HEALTH

01419HKEX

Unit: HKD	FY2026	FY2025	FY2024	FY2023	FY2022
Revenue	671.67 m HKD	644.43 m HKD	590.82 m HKD	1 bn HKD	1.12 bn HKD
Cost of revenue	360.32 m HKD	348.97 m HKD	320.97 m HKD	408.51 m HKD	462.11 m HKD
Selling, general and administrative expense	205.35 m HKD	197.7 m HKD	184.47 m HKD	211.18 m HKD	166.7 m HKD
Operating profit after depreciation	39.27 m HKD	30.29 m HKD	18.15 m HKD	307.07 m HKD	428.81 m HKD
Operating profit before depreciation	106.17 m HKD	97.99 m HKD	86.16 m HKD	381.86 m HKD	491.88 m HKD
EBIT	39.27 m HKD	30.29 m HKD	18.15 m HKD	307.07 m HKD	428.81 m HKD
EBITDA	106.17 m HKD	97.99 m HKD	86.16 m HKD	381.86 m HKD	491.88 m HKD
Interest expense	6.5 m HKD	6.55 m HKD	8.22 m HKD	8.3 m HKD	2.93 m HKD
Profit before tax	31.15 m HKD	29.94 m HKD	26.56 m HKD	238.82 m HKD	445.26 m HKD
Income tax expense	2.81 m HKD	3.31 m HKD	2.38 m HKD	57.98 m HKD	69.95 m HKD
Income before extraordinary items	27.13 m HKD	26.34 m HKD	24.19 m HKD	180.84 m HKD	375.31 m HKD
Common dividends	11.77 m HKD	11.39 m HKD	10.63 m HKD	60.73 m HKD	113.87 m HKD
Total dividends	11.77 m HKD	11.39 m HKD	10.63 m HKD	60.73 m HKD	113.87 m HKD

Quotes are end-of-day data. Content is for research purposes and is not investment advice.